Development Level

Tbio 119 | 11,445
Tchem 9 | 1,598
Tdark 9 | 6,588
Tclin 1 | 613

IMPC Phenotype

preweaning lethality, complete... 26 | 979
embryonic lethality prior to o... 9 | 239
embryonic lethality prior to t... 8 | 278
abnormal embryo size 5 | 220
hypoactivity 4 | 132
abnormal heart morphology 3 | 162
abnormal retina morphology 3 | 71
enlarged heart 3 | 210
abnormal behavior 2 | 298
abnormal body wall morphology 2 | 9
abnormal craniofacial morpholo... 2 | 33
abnormal skin morphology 2 | 50
decreased vertical activity 2 | 208
increased circulating potassiu... 2 | 29
preweaning lethality, incomple... 2 | 499
abnormal epididymis morphology 1 | 42
abnormal forebrain morphology 1 | 10
abnormal hindbrain morphology 1 | 10
abnormal kidney morphology 1 | 65
abnormal midbrain morphology 1 | 10
abnormal neural tube closure 1 | 46
abnormal pericardium morpholog... 1 | 26
abnormal placenta size 1 | 20
abnormal retinal inner nuclear... 1 | 8
abnormal vibrissa morphology 1 | 25
absent startle reflex 1 | 24
brachydactyly 1 | 19
decreased KLRG1+ CD4 alpha bet... 1 | 5
decreased bone mineral density 1 | 126
decreased caudal vertebrae num... 1 | 53
decreased circulating alkaline... 1 | 46
decreased circulating sodium l... 1 | 22
decreased lean body mass 1 | 135
decreased lymphocyte cell numb... 1 | 83
decreased prepulse inhibition 1 | 82
decreased startle reflex 1 | 75
decreased total retina thickne... 1 | 17
edema 1 | 59
embryonic growth retardation 1 | 106
enlarged epididymis 1 | 31
enlarged spleen 1 | 41
female infertility 1 | 60
increased anti-nuclear antigen... 1 | 19
increased circulating HDL chol... 1 | 80
increased circulating alkaline... 1 | 122
increased circulating free fat... 1 | 20
increased erythrocyte cell num... 1 | 39
increased fasted circulating g... 1 | 76
increased heart rate 1 | 23
increased lean body mass 1 | 172
increased leukocyte cell numbe... 1 | 47
increased monocyte cell number 1 | 63
increased or absent threshold ... 1 | 101
increased total body fat amoun... 1 | 134
male infertility 1 | 123
prenatal lethality prior to he... 1 | 87
protruding tongue 1 | 3
short tibia 1 | 97
shortened RR interval 1 | 17

Disease

ovarian cancer 83 | 8,520
Carcinoma 82 | 11,493
osteosarcoma 55 | 7,950
lung cancer 54 | 4,740
psoriasis 38 | 6,694
medulloblastoma, large-cell 35 | 6,241
group 3 medulloblastoma 31 | 4,104
Multiple myeloma 30 | 1,332
atypical teratoid / rhabdoid tumor 30 | 5,112
glioblastoma 30 | 5,792
Breast cancer 26 | 3,578
Kidney cancer 22 | 2,613
ependymoma 22 | 4,679
primitive neuroectodermal tumor 22 | 3,035
malignant mesothelioma 20 | 3,232
adult high grade glioma 19 | 3,801
oligodendroglioma 19 | 2,850
dermatomyositis 18 | 966
Cancer 17 | 2,499
astrocytic glioma 17 | 2,597
acute quadriplegic myopathy 16 | 1,158
Pick disease 15 | 1,894
Waldenstrons macroglobulinemia 15 | 765
intraductal papillary-mucinous neoplasm (IPMN) 15 | 3,291
non-small cell lung cancer 15 | 2,890
Cockayne syndrome 14 | 60
acute myeloid leukemia 13 | 783
diabetes mellitus 13 | 1,728
Photosensitive trichothiodystrophy 12 | 30
invasive ductal carcinoma 12 | 2,951
Astrocytoma, Pilocytic 11 | 3,081
lung adenocarcinoma 11 | 2,716
pancreatic ductal adenocarcinoma liver metastasis 11 | 1,962
tuberculosis 11 | 2,010
Xeroderma pigmentosum group B 10 | 20
astrocytoma 10 | 1,146
breast carcinoma 10 | 1,638
group 4 medulloblastoma 10 | 1,855
Intellectual disability 9 | 1,016
intraductal papillary-mucinous carcinoma (IPMC) 9 | 2,989
subependymal giant cell astrocytoma 9 | 2,287
Autosomal recessive predisposition 8 | 1,442
juvenile dermatomyositis 8 | 1,187
pediatric high grade glioma 8 | 1,064
colon cancer 7 | 1,478
pancreatic cancer 7 | 2,398
spina bifida 7 | 1,074
ulcerative colitis 7 | 1,819
Atopic dermatitis 6 | 952
Dull intelligence 6 | 645
Low intelligence 6 | 645
Mental Retardation 6 | 645
Mental deficiency 6 | 645
Poor school performance 6 | 645
Xeroderma pigmentosum group D 6 | 33
intraductal papillary-mucinous adenoma (IPMA) 6 | 2,955
primary pancreatic ductal adenocarcinoma 6 | 1,109
progressive supranuclear palsy 6 | 676
Epidermodysplasia verruciformis 5 | 21
Muscle Spasticity 5 | 195
Rheumatoid arthritis 5 | 1,191
Xeroderma pigmentosum 5 | 43
adrenocortical carcinoma 5 | 1,428
ductal carcinoma in situ 5 | 1,745
hepatocellular carcinoma 5 | 547
lung carcinoma 5 | 2,843
medulloblastoma 5 | 720
nasopharyngeal carcinoma 5 | 1,058
Amyotrophic lateral sclerosis 4 | 451
Cataract 4 | 297
Cerebellar Ataxia 4 | 304
Cognitive delay 4 | 608
Dystonia 4 | 164
Epilepsy 4 | 792
Failure to gain weight 4 | 365
Global developmental delay 4 | 608
HIV Infections 4 | 102
Hereditary spherocytosis type 5 4 | 12
Hypoplastic mandible condyle 4 | 275
Keratitis 4 | 62
Mandibular hypoplasia 4 | 275
Mental and motor retardation 4 | 608
Micrognathism 4 | 275
Optic Atrophy 4 | 242
Pediatric failure to thrive 4 | 365
Seizures 4 | 596
Small head 4 | 374
Trichothiodystrophy Syndromes 4 | 6
Xeroderma pigmentosum group G 4 | 16
aldosterone-producing adenoma 4 | 665
non primary Sjogren syndrome sicca 4 | 891
pituitary cancer 4 | 1,972
Anemia 3 | 365
Endometrial cancer 3 | 311
Leukemia 3 | 104
Schizophrenia 3 | 1,160
Strabismus 3 | 270
cystic fibrosis 3 | 1,696
pancreatic carcinoma 3 | 562
sonic hedgehog group medulloblastoma 3 | 467

Tissue

Endocrine System 134 | 18,159
Blood and immune system 133 | 16,909
Digestive Tract 133 | 17,369
Female tissues 133 | 17,400
Liver and Pancreas 133 | 16,750
Nervous System 133 | 16,725
Respiratory system 133 | 16,393
Skin and soft tissues 133 | 17,230
Urinary Tract 133 | 16,678
Male tissues 132 | 17,142
Cardiovascular System 131 | 15,192

Target Family

Non-IDG 98 | 12,091
Enzyme 34 | 4,145
Kinase 3 | 634
Epigenetic 2 | 242
Transcription Factor 1 | 1,400

Reactome Pathway

Late Phase of HIV Life Cycle 138 | 138
Signal Transduction 2,657 | 2,657
Immune System 2,101 | 2,101
Metabolism of proteins 2,091 | 2,091
Metabolism 2,081 | 2,081
Post-translational protein mod... 1,398 | 1,398
Gene expression (Transcription... 1,369 | 1,369
RNA Polymerase II Transcriptio... 1,228 | 1,228
Signaling by GPCR 1,217 | 1,217
Innate Immune System 1,176 | 1,176
GPCR downstream signalling 1,157 | 1,157
Generic Transcription Pathway 1,108 | 1,108
Developmental Biology 1,026 | 1,026
Adaptive Immune System 892 | 892
Disease 879 | 879
Cytokine Signaling in Immune s... 752 | 752
Metabolism of lipids 739 | 739
Vesicle-mediated transport 720 | 720
Transport of small molecules 717 | 717
Metabolism of RNA 682 | 682
Hemostasis 666 | 666
Membrane Trafficking 608 | 608
Cell Cycle 590 | 590
G alpha (s) signalling events 574 | 574
Neutrophil degranulation 539 | 539
Axon guidance 533 | 533
Cell Cycle, Mitotic 488 | 488
Cellular responses to external... 463 | 463
GPCR ligand binding 459 | 459
Signaling by Interleukins 448 | 448
Class I MHC mediated antigen p... 435 | 435
Signaling by Receptor Tyrosine... 430 | 430
Olfactory Signaling Pathway 428 | 428
Infectious disease 404 | 404
G alpha (i) signalling events 394 | 394
Cellular responses to stress 386 | 386
Signaling by Rho GTPases 386 | 386
Metabolism of amino acids and ... 370 | 370
Diseases of signal transductio... 367 | 367
Neuronal System 367 | 367
Transcriptional Regulation by ... 365 | 365
M Phase 344 | 344
Class A/1 (Rhodopsin-like rece... 322 | 322
Antigen processing: Ubiquitina... 306 | 306
Extracellular matrix organizat... 297 | 297
Translation 297 | 297
Signaling by WNT 293 | 293
Intracellular signaling by sec... 289 | 289
DNA Repair 288 | 288
Asparagine N-linked glycosylat... 287 | 287
MAPK family signaling cascades 285 | 285
Deubiquitination 276 | 276
Interferon Signaling 275 | 275
Immunoregulatory interactions ... 272 | 272
Metabolism of carbohydrates 271 | 271
Cell Cycle Checkpoints 270 | 270
Organelle biogenesis and maint... 261 | 261
PIP3 activates AKT signaling 259 | 259
RHO GTPase Effectors 257 | 257
Platelet activation, signaling... 256 | 256
HIV Infection 254 | 254
MAPK1/MAPK3 signaling 244 | 244
SLC-mediated transmembrane tra... 243 | 243
Processing of Capped Intron-Co... 238 | 238
RAF/MAP kinase cascade 238 | 238
Chromatin modifying enzymes 236 | 236
Chromatin organization 236 | 236
Neddylation 234 | 234
Transmission across Chemical S... 221 | 221
Biological oxidations 220 | 220
Signaling by ROBO receptors 219 | 219
Keratinization 216 | 216
rRNA processing 216 | 216
G alpha (q) signalling events 211 | 211
Cell surface interactions at t... 210 | 210
Phospholipid metabolism 209 | 209
Fc epsilon receptor (FCERI) si... 204 | 204
Transcriptional regulation by ... 203 | 203
Ub-specific processing proteas... 203 | 203
TCF dependent signaling in res... 199 | 199
Muscle contraction 198 | 198
rRNA processing in the nucleus... 192 | 192
Metabolism of vitamins and cof... 188 | 188
Peptide ligand-binding recepto... 188 | 188
mRNA Splicing 187 | 187
Cilium Assembly 186 | 186
Intra-Golgi and retrograde Gol... 186 | 186
Mitotic G2-G2/M phases 184 | 184
Mitotic Metaphase and Anaphase 183 | 183
G2/M Transition 182 | 182
Major pathway of rRNA processi... 182 | 182
Mitotic Anaphase 182 | 182
Mitotic Prometaphase 181 | 181
Fatty acid metabolism 180 | 180
mRNA Splicing - Major Pathway 179 | 179
Ion channel transport 177 | 177
Signaling by the B Cell Recept... 176 | 176
Regulation of expression of SL... 173 | 173
Programmed Cell Death 172 | 172
Interferon gamma signaling 171 | 171
Separation of Sister Chromatid... 170 | 170

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Nucleoporin NDC1 NDC1 Tbio Non-IDG -0.66901 4.57 46
Negative elongation factor B NELFB Tbio Non-IDG -1.16040 16.4 158
DNA-directed RNA polymerase II subunit RPB2 POLR2B Tbio Enzyme -2.49730 299.8 149
Charged multivesicular body protein 7 CHMP7 Tbio Non-IDG -0.61033 3.61 30
Tumor susceptibility gene 101 protein TSG101 Tbio Non-IDG -2.47780 298.9 332
Charged multivesicular body protein 3 CHMP3 Tbio Non-IDG -1.39658 35.6 64
Transcription initiation factor TFIID subunit 9B TAF9B Tbio Non-IDG -1.38372 23.5 105
Programmed cell death 6-interacting protein PDCD6IP Tbio Non-IDG -1.59404 35.1 216
Nucleoprotein TPR TPR Tbio Non-IDG -2.11491 135.6 161
DNA-directed RNA polymerases I, II, and III subunit RPABC2 POLR2F Tbio Enzyme -1.13403 13.9 68